Perspective Therapeutics Inc. (CATX) — Cash Flow Reinvestment Rate

Latest as of September 2024: 17.66x

Perspective Therapeutics Inc. (CATX) has a Cash Flow Reinvestment Rate of 17.66x as of September 2024, reinvesting $59.45 Million (capex $29.71 Million plus investments $-29.74 Million) from operating cash flow of $3.37 Million. Check CATX cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

17.66x
(Capex + Investments) / Operating CF

Total Reinvested

$59.45 Million
Capex + Investments

Operating Cash Flow

$3.37 Million
USD

Capital Expenditures

$29.71 Million
USD

Perspective Therapeutics Inc. Cash Flow Reinvestment Rate (1999–2001)

Historical reinvestment intensity for Perspective Therapeutics Inc. across 4 annual periods. Explore Perspective Therapeutics Inc. (CATX) investment intensity to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for Perspective Therapeutics Inc. (1999–2001)

Year-by-year capital reinvestment analysis for Perspective Therapeutics Inc.. For live market cap and broader valuation context, see CATX market cap overview.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2001 0.13x $48.81K $365.34K $48.81K ▲ +0.0%
2000 0.13x $48.81K $365.34K $48.81K ▼ -76.9%
1999 0.58x $159.58K $275.97K $159.58K ▲ +0.0%
1999 0.58x $159.58K $275.97K $159.58K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow